Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Rajendra Baliga"'
Autor:
Samih H. Nasr, Julie A. Vrana, Liying Fu, Rajendra Baliga, Surendra Dasari, Jason D. Theis, Huma Fatima, Octavio Chavez, Ellen D. McPhail
Publikováno v:
Kidney Medicine
The occurrence of renal amyloidosis and fibrillary glomerulonephritis in the same biopsy specimen is exceptional and poses a diagnostic challenge. We describe the case of a non-Hispanic White patient with end-stage kidney disease due to fibrillary gl
Autor:
Martin Aldana-Campos, Mayra Lopez-Cepero, Luis Beltran-Garcia, John G. Lunz, Sandra Resto-Ruiz, Rajendra Baliga, Helen Schmidt
Publikováno v:
Human Immunology. 80:195
Publikováno v:
Human Pathology. 39:550-556
Calcineurin inhibitor (CI) toxicity in renal allografts is frequently associated with arteriolar injury. Platelet activation occurs in response to vascular injury associated with CI therapy. Platelets are detectable in tissue sections by immunohistoc
Autor:
John P, Leone, Victor, Bowers, Rajendra, Baliga, Charles, Sanders, William, LeFor, Donna, Becker, Dawn, Thompson, Sandra, Resto-Ruiz, Mayra, Lopez-Cepero
Publikováno v:
Clinical transplants.
Although the adverse allograft outcomes associated with HLA antibodies are well documented, some controversy exists regarding the importance of low-level donor specific anti-HLA antibodies (DSA). To provide further detail on this controversy, we pros
Autor:
Shane Meehan, Anthony Chang, Rajendra Baliga, Pradeep V. Kadambi, Amandeep Khurana, Basit Javaid
Background and objectives: Glomerular lesions in allografts in recipients with end-stage nephritis resulting from systemic lupus erythematosus (SLE) were examined to determine the spectrum of glomerular pathology in recurrent glomerulonephritis (GN).
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a96597bcf0a5ad84502126c1335c0bdb
https://europepmc.org/articles/PMC2518796/
https://europepmc.org/articles/PMC2518796/
Publikováno v:
Transplantation. 75(8)
Chronic kidney disease is thought to be a potential risk factor for cardiovascular death. In renal-allograft recipients, cardiovascular disease is the most significant cause of death. The purpose of this study was to investigate if renal function has
Autor:
Donna Becker, Dawn Thompson, Mayra Lopez-Cepero, Rajendra Baliga, Sandra Resto-Ruiz, Charles Sanders, Victor Bowers, John Leone
Publikováno v:
Human Immunology. 73:71
Aim Multiple clinical studies have shown the adverse effect of HLA antibodies on graft survival, either pre- formed or de novo antibodies post-transplant. The current utilization of more sensitive assays like solid phase assays (SPA) and multiplex te